Arabian Journal of Chemistry,
Journal Year:
2023,
Volume and Issue:
16(8), P. 104956 - 104956
Published: May 3, 2023
New
thiadiazole
sulfonamide
derivatives
were
designed
as
human
carbonic
anhydrase
inhibitors
(hCAIs)
to
develop
robust
and
novel
anticancer
agents.
Tail
modification
approach
was
considered
in
designing
the
target
compounds
which
synthesized
following
two-step
procedure
starting
from
5-acetyl-3-N-(4-sulfamoylphenyl)-2-imino-1,3,4-thiadiazoline.
Cytotoxic
evaluation
revealed
potent
diazene
derivative
2
with
IC50
1.18
μM,
5.28
μM
7.15
against
MCF-7,
Caco2
HepG-2,
respectively.
Moreover,
dihydroxyphenyl
triazene
5
demonstrated
3.03
5.66
12.50
Caco2,
HepG-2
Similarly,
carbohydrazide
coumarin
18
showed
of
2.00
12.30
HepG2,
Molecular
docking
using
hCAIX
hCAXII
adopted
explain
achieved
cytotoxicity
on
molecular
level
their
silico
ADME
evaluation.
Cancers,
Journal Year:
2022,
Volume and Issue:
14(14), P. 3297 - 3297
Published: July 6, 2022
Carbonic
Anhydrase
IX
(CAIX)
is
a
major
metabolic
effector
of
tumor
hypoxia
and
regulates
intra-
extracellular
pH
acidosis.
Significant
advances
have
been
made
recently
in
the
development
therapeutic
targeting
CAIX.
These
approaches
include
antibody-based
immunotherapy,
as
well
use
antibodies
to
deliver
toxic
radioactive
payloads.
In
addition,
large
number
small
molecule
inhibitors
which
inhibit
enzymatic
activity
CAIX
described.
this
commentary,
we
highlight
current
status
strategies
both
pre-clinical
clinical
space,
discuss
future
perspectives
that
leverage
inhibition
combination
with
additional
targeted
therapies
enable
effective,
durable
for
cancer
therapy.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer,
Journal Year:
2024,
Volume and Issue:
1879(4), P. 189120 - 189120
Published: May 25, 2024
Carbonic
anhydrases
(CAs),
are
metallo-enzymes
implicated
in
several
pathophysiological
processes
where
tissue
pH
regulation
is
required.
CA
IX
a
tumor-associated
isoform
induced
by
hypoxia
and
involved
the
adaptation
of
tumor
cells
to
acidosis.
Indeed,
tumor-driving
pathways
can
induce
expression,
this
turn
has
been
associated
cancer
invasion
metastatic
features
as
well
induction
stem-like
features,
drug
resistance
recurrence.
After
its
functional
structural
characterization
targeting
approaches
have
developed
inhibit
activity
neoplastic
tissues,
date
field
seen
an
incredible
acceleration
terms
therapeutic
options
biological
readouts.
Small
molecules
inhibitors,
hybrid/dual
drugs,
antibodies
adoptive
(CAR-T
based)
cell
therapy
at
preclinical
level,
whereas
sulfonamide
inhibitor
antibody
entered
Phase
Ib/II
clinical
trials
for
treatment
imaging
different
solid
tumors.
Here
recent
advances
on
biology
pharmacology
cancer,
will
be
discussed.
Journal of Biomolecular Structure and Dynamics,
Journal Year:
2023,
Volume and Issue:
41(21), P. 11657 - 11670
Published: Jan. 25, 2023
Tropomyosin
receptor
kinase
(TRK)
enzymes
are
responsible
for
different
types
of
tumors
caused
by
neurotrophic
tyrosine
gene
fusion
and
have
been
identified
as
an
effective
target
anticancer
therapy.
The
study
the
mechanism
between
polo-like
(PLKs)
pyrazol
inhibitors
was
performed
using
3D-QSAR
modeling,
molecular
docking,
MD
simulations
in
order
to
design
high-activity
inhibitors.
HQSAR
(Q2
=
0.793,
R2
0.917,
R2ext
0.961),
CoMFA
0.582,
0.722,
0.951),
CoMSIA/SE
0.603,
0.801,
0.849),
Topomer
0.726,
0.992,
0.717)
showed
good
reliability
predictability.
All
models
successfully
tested
external
validation,
so
all
five
established
reliable.
analysis
contour
maps
gives
structural
information
improve
inhibitory
function.
Molecular
docking
results
show
that
amino
acids
Met
592,
GLU
590,
LEU
657,
VAL
524,
PHE
589
active
sites
tropomyosin
TRKs.
obtained
compound
19i
could
form
a
more
stable
complex
protein
(PDB
id:
5KVT).
Based
on
these
results,
we
developed
new
compounds
their
expected
activities.
physicochemical
ADME-Tox
properties
four
proposed
molecules
orally
bioavailable,
they
not
toxic
Ames
test.
Thus,
would
provide
modeling
help
experimental
researchers
find
TRK
type
I
efficiently.Communicated
Ramaswamy
H.
Sarma.
Molecules,
Journal Year:
2024,
Volume and Issue:
29(19), P. 4770 - 4770
Published: Oct. 9, 2024
Indole
derivatives
have
become
an
important
class
of
compounds
in
medicinal
chemistry,
recognized
for
their
wide-ranging
biological
activities
and
therapeutic
potential.
This
review
provides
a
comprehensive
overview
recent
advances
the
evaluation
indole-based
last
five
years,
highlighting
roles
cancer
treatment,
infectious
disease
management,
anti-inflammatory
therapies,
metabolic
disorder
interventions,
neurodegenerative
management.
shown
significant
efficacy
targeting
diverse
pathways,
making
them
valuable
scaffolds
designing
new
drugs.
Notably,
these
demonstrated
ability
to
combat
drug-resistant
cells
pathogens,
breakthrough
field,
offer
promising
options
chronic
diseases
such
as
diabetes
hypertension.
By
summarizing
key
findings
exploring
underlying
mechanisms,
this
underscores
potential
indole
addressing
major
healthcare
challenges,
thereby
instilling
hope
optimism
field
modern
medicine.
Journal of Nanobiotechnology,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: Jan. 24, 2025
The
acidic
tumor
microenvironment,
a
hallmark
of
many
solid
tumors,
is
primarily
induced
by
the
high
glycolytic
rate
cells.
To
avoid
acidosis,
cells
ingeniously
maintain
an
extracellular
pH
while
keeping
relatively
alkaline
intracellular
pH.
Overturning
unique
gradient
has
exhibited
to
be
viable
approach
for
cancer
therapy.
In
this
review,
formation
and
regulatory
mechanisms
microenvironment
in
tumors
will
firstly
outlined.
Subsequently,
we
comprehensively
summarize
latest
advancements
anti-tumor
therapy
via
using
nanomedicines
manipulate
gradient,
including
acidifying
environment
alkalizing
environment.
Following
this,
discuss
future
potential
strategies
employing
reverse
gradient.
This
review
aims
foster
research
on
therapeutic
approaches
targeting
regulation
holds
optimistic
outlook
development
field.
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(11), P. 5892 - 5892
Published: May 24, 2022
Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine
sulfonamides
constitute
a
novel
class
of
heterocyclic
compounds
with
broad
biological
activity,
including
anticancer
properties.
Investigated
in
this
study,
MM-compounds
(MM134,
MM136,
MM137,
and
MM139)
exhibited
cytotoxic
proapoptotic
activity
against
cancer
cell
lines
(BxPC-3,
PC-3,
HCT-116)
nanomolar
concentrations
without
causing
cytotoxicity
normal
cells
(L929
WI38).
In
silico
predictions
indicate
that
tested
exhibit
favorable
pharmacokinetic
profiles
may
exert
through
the
inhibition
BTK
kinase,
AKT-mTOR
pathway
PD1-PD-L1
interaction.
Our
findings
point
out
these
sulfonamide
derivatives
source
new
drugs
after
optimization.
Frontiers in Oncology,
Journal Year:
2023,
Volume and Issue:
13
Published: July 10, 2023
The
tumor
microenvironment
(TME)
is
characterized
by
interactions
among
various
cells,
including
immune
stromal
and
blood
vessels
mediated
factors
such
as
cytokines
metabolites.
development
of
cancer
immunotherapy
in
recent
years
has
facilitated
a
more
comprehensive
understanding
the
TME.
TME
changes
with
type
host
status,
well
therapeutic
intervention.
However,
studies
on
pH
regulation
have
been
mostly
based
lactate,
metabolite
cells.
Notably,
Warburg
effect
results
increased
production
secreted
thereby
acidifying
extracellular
affecting
surrounding
Lactate
inhibits
activation
proliferation
CD8+
T
M1
macrophages,
natural
killer
(NK)
dendritic
contributing
to
cell
escape.
It
also
involved
angiogenesis
tissue
remodeling,
promotes
growth
invasion.
In
this
review,
we
discussed
lactate-based
cells
its
effects
other
constituent